Reproducibility and usefulness of quantitative apparent diffusion coefficient measurements for predicting program death-ligand 1 expression in nasopharyngeal carcinoma

被引：0
|
作者：
Xi Zhong
Li Li
Jinxue Yin
Yuanlin Chen
Xin Xin
Lanlan Yu
Yongfang Tang
Jiangyu Zhang
Jiansheng Li
机构：
[1] Affiliated Cancer Hospital & Institute of Guangzhou Medical University,Department of Medical Imaging
[2] The Third Affiliated Hospital of Guangzhou Medical University,Department of Otolaryngology
[3] Affiliated Cancer Hospital & Institute of Guangzhou Medical University,Department of Pathology
来源：
Cancer Imaging | / 23卷
关键词：
Nasopharyngeal carcinoma; Programmed death ligand 1; Magnetic resonance imaging; Apparent diffusion coefficients;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Clinical significance of programmed death-1 and programmed death-ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma
    Mikami, Shuji
    Mizuno, Ryuichi
    Kondo, Tsunenori
    Shinohara, Nobuo
    Nonomura, Norio
    Ozono, Seiichiro
    Eto, Masatoshi
    Tatsugami, Katsunori
    Takayama, Tatsuya
    Matsuyama, Hideyasu
    Kishida, Takeshi
    Oya, Mototsugu
    CANCER SCIENCE, 2019, 110 (06) : 1820 - 1828
  • [42] Interferon Gamma Receptor 2 Collaborates With Circular RNA/MicroRNA to Modulate Programmed Cell Death-Ligand 1 Levels in Nasopharyngeal Carcinoma
    Guan, Guo Fang
    Fu, Ze Ming
    Zhang, De Jun
    Guo, Ying Yuan
    Guo, Fang
    Wan, Yi Ning
    Bai, Jie
    Zhao, Ying
    WORLD JOURNAL OF ONCOLOGY, 2024, 15 (06) : 929 - 941
  • [43] MAP kinase phosphatase (Mkp)-1 Controls Program Death-Ligand (PD-L)1 Expression during Sepsis
    Kirk, Sean G.
    Batty, Abel J.
    Wang, Xiantao
    Li, Jinhui
    White, William M.
    Ackerman, William E.
    Nelin, Leif D.
    Buhimschi, Irina
    Hafner, Markus
    Liu, Yusen
    JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
  • [44] Programmed Cell Death-Ligand 1 (PD-L1) Expression in Oral Cavity Squamous Cell Carcinoma (OSCC)
    Satgunaseelan, Laveniya
    Madore, Jason
    Chia, Noel
    Lum, Trina
    Palme, Carsten E.
    Boyer, Michael
    Scolyer, Richard A.
    Clark, Jonathan R.
    Gupta, Ruta
    MODERN PATHOLOGY, 2016, 29 : 329A - 329A
  • [45] Programmed Death-Ligand 1 Expression, Microsatellite Instability, Epstein–Barr Virus, and Human Papillomavirus in Nasopharyngeal Carcinomas of Patients from the Philippines
    Chang A.M.V.
    Chiosea S.I.
    Altman A.
    Pagdanganan H.A.
    Ma C.
    Head and Neck Pathology, 2017, 11 (2) : 203 - 211
  • [46] Programmed Cell Death-Ligand 1 (PD-L1) Expression in Oral Cavity Squamous Cell Carcinoma (OSCC)
    Satgunaseelan, Laveniya
    Madore, Jason
    Chia, Noel
    Lum, Trina
    Palme, Carsten E.
    Boyer, Michael
    Scolyer, Richard A.
    Clark, Jonathan R.
    Gupta, Ruta
    LABORATORY INVESTIGATION, 2016, 96 : 329A - 329A
  • [47] PROGRAMMED DEATH-LIGAND (PD-L1) EXPRESSION AND LYMPH NODE INVOLVEMENT IN PENILE SQUAMOUS CELL CARCINOMA
    Peyroteo, Ines
    Santos, Filipa
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1010 - E1011
  • [48] Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma
    Ock, Chan-Young
    Kim, Sehui
    Keam, Bhumsuk
    Kim, Soyeon
    Ahn, Yong-Oon
    Chung, Eun-Jae
    Kim, Jin-Ho
    Kim, Tae Min
    Kwon, Seong Keun
    Jeon, Yoon Kyung
    Jung, Kyeong Chun
    Kim, Dong-Wan
    Wu, Hong-Gyun
    Sung, Myung-Whun
    Heo, Dae Seog
    ONCOTARGET, 2017, 8 (58) : 97920 - 97927
  • [49] Editorial Comment to Programmed cell death-ligand 1 expression in different molecular subtypes of upper tract urothelial carcinoma
    Kijima, Toshiki
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (01) : 91 - 91
  • [50] Expression of programmed death-ligand 1 protein in pulmonary squamous cell carcinoma correlates with tumour necrosis but not with tumour differentiation
    Tancos, Vladimir
    Farkasova, Anna
    Kviatkovska, Zuzana
    Grendar, Marian
    Liskova, Alena
    Hut'ka, Zdenko
    Plank, Lukas
    JOURNAL OF CLINICAL PATHOLOGY, 2022, 75 (06) : 373 - 378
12345